At a certain point, ignorance is willful. The psychedelic community has refused to learn critical lessons about ethics and safety… we are having these conversations at the dawn of medicalization. The problem is… bad ideas… they go back to the earliest days of psychedelic research and psychedelics as a cultural phenomenon within industrial contexts. Abuse…
…a 35-percent response rate and a 5-percent SAE rate means for every seven patients positively responding to the treatment, one person will experience serious negative outcomes… these serious adverse events included suicidal ideation and suicidal behavior. Five patients (6.3 percent) in the 25-mg group and six patients (8 percent) in the 10-mg group experienced at…
Psychedelic psilocybin was approved by voters last fall for limited, therapeutic use, but “remains a Schedule 1 controlled substance,” the sergeant noted… during the search of the home, detectives found an active psilocybin grow chamber in the children’s play area and toy storage area, the sergeant said. The man was cited and released at the…
The panel asked the city council in its report to “make the communal use of psilocybin among the lowest law enforcement priorities.” In a 56-page long document submitted to the Denver City Council’s Finance and Governance Committee, the Denver Psilocybin Mushroom Policy Review Panel (DPMPR) members emphasized the expansion of decriminalization for gifting and communal sharing…
“Arrests related to psilocybin decreased by more than half since the passage of I-301,” the review panel’s recent report notes… arrests involving mushrooms in Denver are down 50% compared to before decriminalization and, of arrests involving mushrooms, 89% include other illicit substances. Mushrooms also account for less than 1% of drug felonies and misdemeanors in…
They helped create the disease, and now they want to hoard the cure. This was the plug for Prozac when it first came on the market in 1988… no matter: a new therapeutic savior has arrived in the form of psychedelics. If you think it’s a little strange that Big Tech – currently best known…
The fact that someone who tried psychedelics for the first time in 2014 now talks openly about restricting access to them might be unsettling to many in the psychedelic community. But some investors are already adopting a gatekeeping approach to these ancient medicines. For example, German billionaire Christian Angermayer, founder of biotech company Atai Life…
Unfounded claims that psychedelic drugs have no medical uses, as the US Congress once declared, and are fundamentally dangerous, kept research endeavours in a straitjacket… Decriminalize Nature, which argues humans have an unalienable right to develop their own relationship with natural plants, persuaded US authorities in half a dozen municipalities, including Washington DC, to decriminalise…
With… propriety technology… stable formulations of both psilocin and psilocybin from magic mushrooms. …drug development efforts are focused exclusively on extracting, purifying, and standardizing natural psychedelic compounds. Original Article (Psychedelic Spotlight):FDA approves first clinical trial using naturally sourced psychedelicsArtwork Fair Use: Perdula
Their research was not cited in the patent application. Yet, if this patent application was granted… it could block others… The application, published on May 20 2020, was originally filed on November 15, 2019. (Patent applications are kept secret for 18 months)… the application has claims on organisms genetically modified to produce psilocybin by giving them…
Recent Comments